The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetes Lancets for Home Market Research Report 2024
Synopsis
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
Global Diabetes Lancets for Home market is projected to reach US$ 1503.2 million in 2029, increasing from US$ 1057 million in 2022, with the CAGR of 5.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Diabetes Lancets for Home market research.
The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Diabetes Lancets for Home market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets with Needle
Safety Lancets with Blade
Segment by Application
Hospital
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Diabetes Lancets for Home report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
Global Diabetes Lancets for Home market is projected to reach US$ 1503.2 million in 2029, increasing from US$ 1057 million in 2022, with the CAGR of 5.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Diabetes Lancets for Home market research.
The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Diabetes Lancets for Home market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets with Needle
Safety Lancets with Blade
Segment by Application
Hospital
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Diabetes Lancets for Home report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Diabetes Lancets for Home Market Overview
1.1 Product Overview and Scope of Diabetes Lancets for Home
1.2 Diabetes Lancets for Home Segment by Type
1.2.1 Global Diabetes Lancets for Home Market Value Comparison by Type (2023-2029)
1.2.2 Safety Lancets with Needle
1.2.3 Safety Lancets with Blade
1.3 Diabetes Lancets for Home Segment by Application
1.3.1 Global Diabetes Lancets for Home Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Diabetes Lancets for Home Market Size Estimates and Forecasts
1.4.1 Global Diabetes Lancets for Home Revenue 2018-2029
1.4.2 Global Diabetes Lancets for Home Sales 2018-2029
1.4.3 Global Diabetes Lancets for Home Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Diabetes Lancets for Home Market Competition by Manufacturers
2.1 Global Diabetes Lancets for Home Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diabetes Lancets for Home Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diabetes Lancets for Home Average Price by Manufacturers (2018-2023)
2.4 Global Diabetes Lancets for Home Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Diabetes Lancets for Home, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetes Lancets for Home, Product Type & Application
2.7 Diabetes Lancets for Home Market Competitive Situation and Trends
2.7.1 Diabetes Lancets for Home Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetes Lancets for Home Players Market Share by Revenue
2.7.3 Global Diabetes Lancets for Home Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Lancets for Home Retrospective Market Scenario by Region
3.1 Global Diabetes Lancets for Home Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Diabetes Lancets for Home Global Diabetes Lancets for Home Sales by Region: 2018-2029
3.2.1 Global Diabetes Lancets for Home Sales by Region: 2018-2023
3.2.2 Global Diabetes Lancets for Home Sales by Region: 2024-2029
3.3 Global Diabetes Lancets for Home Global Diabetes Lancets for Home Revenue by Region: 2018-2029
3.3.1 Global Diabetes Lancets for Home Revenue by Region: 2018-2023
3.3.2 Global Diabetes Lancets for Home Revenue by Region: 2024-2029
3.4 North America Diabetes Lancets for Home Market Facts & Figures by Country
3.4.1 North America Diabetes Lancets for Home Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Diabetes Lancets for Home Sales by Country (2018-2029)
3.4.3 North America Diabetes Lancets for Home Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diabetes Lancets for Home Market Facts & Figures by Country
3.5.1 Europe Diabetes Lancets for Home Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Diabetes Lancets for Home Sales by Country (2018-2029)
3.5.3 Europe Diabetes Lancets for Home Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetes Lancets for Home Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetes Lancets for Home Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Diabetes Lancets for Home Sales by Country (2018-2029)
3.6.3 Asia Pacific Diabetes Lancets for Home Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Diabetes Lancets for Home Market Facts & Figures by Country
3.7.1 Latin America Diabetes Lancets for Home Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Diabetes Lancets for Home Sales by Country (2018-2029)
3.7.3 Latin America Diabetes Lancets for Home Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetes Lancets for Home Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetes Lancets for Home Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Diabetes Lancets for Home Sales by Country (2018-2029)
3.8.3 Middle East and Africa Diabetes Lancets for Home Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetes Lancets for Home Sales by Type (2018-2029)
4.1.1 Global Diabetes Lancets for Home Sales by Type (2018-2023)
4.1.2 Global Diabetes Lancets for Home Sales by Type (2024-2029)
4.1.3 Global Diabetes Lancets for Home Sales Market Share by Type (2018-2029)
4.2 Global Diabetes Lancets for Home Revenue by Type (2018-2029)
4.2.1 Global Diabetes Lancets for Home Revenue by Type (2018-2023)
4.2.2 Global Diabetes Lancets for Home Revenue by Type (2024-2029)
4.2.3 Global Diabetes Lancets for Home Revenue Market Share by Type (2018-2029)
4.3 Global Diabetes Lancets for Home Price by Type (2018-2029)
5 Segment by Application
5.1 Global Diabetes Lancets for Home Sales by Application (2018-2029)
5.1.1 Global Diabetes Lancets for Home Sales by Application (2018-2023)
5.1.2 Global Diabetes Lancets for Home Sales by Application (2024-2029)
5.1.3 Global Diabetes Lancets for Home Sales Market Share by Application (2018-2029)
5.2 Global Diabetes Lancets for Home Revenue by Application (2018-2029)
5.2.1 Global Diabetes Lancets for Home Revenue by Application (2018-2023)
5.2.2 Global Diabetes Lancets for Home Revenue by Application (2024-2029)
5.2.3 Global Diabetes Lancets for Home Revenue Market Share by Application (2018-2029)
5.3 Global Diabetes Lancets for Home Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Diabetes Lancets for Home Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BD Diabetes Lancets for Home Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Ascensia
6.3.1 Ascensia Corporation Information
6.3.2 Ascensia Description and Business Overview
6.3.3 Ascensia Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ascensia Diabetes Lancets for Home Product Portfolio
6.3.5 Ascensia Recent Developments/Updates
6.4 Lifescan
6.4.1 Lifescan Corporation Information
6.4.2 Lifescan Description and Business Overview
6.4.3 Lifescan Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lifescan Diabetes Lancets for Home Product Portfolio
6.4.5 Lifescan Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Diabetes Lancets for Home Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo Diabetes Lancets for Home Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Nipro
6.6.1 Nipro Corporation Information
6.6.2 Nipro Description and Business Overview
6.6.3 Nipro Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nipro Diabetes Lancets for Home Product Portfolio
6.7.5 Nipro Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Corporation Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cardinal Health Diabetes Lancets for Home Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 ARKRAY
6.9.1 ARKRAY Corporation Information
6.9.2 ARKRAY Description and Business Overview
6.9.3 ARKRAY Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ARKRAY Diabetes Lancets for Home Product Portfolio
6.9.5 ARKRAY Recent Developments/Updates
6.10 ICU Medical
6.10.1 ICU Medical Corporation Information
6.10.2 ICU Medical Description and Business Overview
6.10.3 ICU Medical Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ICU Medical Diabetes Lancets for Home Product Portfolio
6.10.5 ICU Medical Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Corporation Information
6.11.2 Owen Mumford Diabetes Lancets for Home Description and Business Overview
6.11.3 Owen Mumford Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Owen Mumford Diabetes Lancets for Home Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 HemoCue
6.12.1 HemoCue Corporation Information
6.12.2 HemoCue Diabetes Lancets for Home Description and Business Overview
6.12.3 HemoCue Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.12.4 HemoCue Diabetes Lancets for Home Product Portfolio
6.12.5 HemoCue Recent Developments/Updates
6.13 Greiner Bio One
6.13.1 Greiner Bio One Corporation Information
6.13.2 Greiner Bio One Diabetes Lancets for Home Description and Business Overview
6.13.3 Greiner Bio One Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Greiner Bio One Diabetes Lancets for Home Product Portfolio
6.13.5 Greiner Bio One Recent Developments/Updates
6.14 HTL-STREFA
6.14.1 HTL-STREFA Corporation Information
6.14.2 HTL-STREFA Diabetes Lancets for Home Description and Business Overview
6.14.3 HTL-STREFA Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.14.4 HTL-STREFA Diabetes Lancets for Home Product Portfolio
6.14.5 HTL-STREFA Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Corporation Information
6.15.2 Sarstedt Diabetes Lancets for Home Description and Business Overview
6.15.3 Sarstedt Diabetes Lancets for Home Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sarstedt Diabetes Lancets for Home Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetes Lancets for Home Industry Chain Analysis
7.2 Diabetes Lancets for Home Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetes Lancets for Home Production Mode & Process
7.4 Diabetes Lancets for Home Sales and Marketing
7.4.1 Diabetes Lancets for Home Sales Channels
7.4.2 Diabetes Lancets for Home Distributors
7.5 Diabetes Lancets for Home Customers
8 Diabetes Lancets for Home Market Dynamics
8.1 Diabetes Lancets for Home Industry Trends
8.2 Diabetes Lancets for Home Market Drivers
8.3 Diabetes Lancets for Home Market Challenges
8.4 Diabetes Lancets for Home Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
